产品标题 产品货号 产品规格 厂家
Human Testis; Fibrosis from ORIGENE TECHNOLOGIESCS6201005x5umORIGENE TECHNOLOGIES
Human Testis; Intratubular germ cell neoplasia of testis from ORIGENE TECHNOLOGIESCS8092875x5umORIGENE TECHNOLOGIES
Human Testis; Intratubular germ cell neoplasia of testis from ORIGENE TECHNOLOGIESCS8092885x5umORIGENE TECHNOLOGIES
Human Testis; Intratubular germ cell neoplasia of testis from ORIGENE TECHNOLOGIESCS8031085x5umORIGENE TECHNOLOGIES
Human Testis; Intratubular germ cell neoplasia of testis from ORIGENE TECHNOLOGIESCS8117145x5umORIGENE TECHNOLOGIES
Human Testis; Intratubular germ cell neoplasia of testis from ORIGENE TECHNOLOGIESCS8117155x5umORIGENE TECHNOLOGIES
Human Testis; Intratubular germ cell neoplasia of testis from ORIGENE TECHNOLOGIESCS8144995x5umORIGENE TECHNOLOGIES
Human Testis; Intratubular germ cell neoplasia of testis from ORIGENE TECHNOLOGIESCS6108255x5umORIGENE TECHNOLOGIES
Preferentially expressed antigen in melanoma (PRAME), transcript variant 1 from ORIGENE TECHNOLOGIESLY401847100 ugORIGENE TECHNOLOGIES
Preferentially expressed antigen in melanoma (PRAME), transcript variant 2 from ORIGENE TECHNOLOGIESLY404191100 ugORIGENE TECHNOLOGIES
Preferentially expressed antigen in melanoma (PRAME), transcript variant 3 from ORIGENE TECHNOLOGIESLY404192100 ugORIGENE TECHNOLOGIES
Preferentially expressed antigen in melanoma (PRAME), transcript variant 4 from ORIGENE TECHNOLOGIESLY404193100 ugORIGENE TECHNOLOGIES
Preferentially expressed antigen in melanoma (PRAME), transcript variant 5 from ORIGENE TECHNOLOGIESLY404194100 ugORIGENE TECHNOLOGIES
Preferentially expressed antigen in melanoma (PRAME), transcript variant 2 from ORIGENE TECHNOLOGIESLY430965100 ugORIGENE TECHNOLOGIES
Preferentially expressed antigen in melanoma (PRAME), transcript variant 5 from ORIGENE TECHNOLOGIESLY430966100 ugORIGENE TECHNOLOGIES
Prefoldin subunit 1 (PFDN1) from ORIGENE TECHNOLOGIESLY419197100 ugORIGENE TECHNOLOGIES
Prefoldin subunit 4 (PFDN4) from ORIGENE TECHNOLOGIESLY419198100 ugORIGENE TECHNOLOGIES
Prefoldin subunit 6 (PFDN6) from ORIGENE TECHNOLOGIESLY415391100 ugORIGENE TECHNOLOGIES
Prefoldin subunit 2 (PFDN2) from ORIGENE TECHNOLOGIESLY415791100 ugORIGENE TECHNOLOGIES
Prefoldin subunit 5 (PFDN5), transcript variant 1 from ORIGENE TECHNOLOGIESLY419199100 ugORIGENE TECHNOLOGIES
Pregnancy specific beta-1-glycoprotein 1 (PSG1) from ORIGENE TECHNOLOGIESLY402056100 ugORIGENE TECHNOLOGIES
Pregnancy specific beta-1-glycoprotein 3 (PSG3) from ORIGENE TECHNOLOGIESLY412142100 ugORIGENE TECHNOLOGIES
Pregnancy specific beta-1-glycoprotein 1 (PSG1), transcript variant 3 from ORIGENE TECHNOLOGIESLY433043100 ugORIGENE TECHNOLOGIES
Pregnancy specific beta-1-glycoprotein 11 (PSG11), transcript variant 1 from ORIGENE TECHNOLOGIESLY419113100 ugORIGENE TECHNOLOGIES
Pregnancy specific beta-1-glycoprotein 11 (PSG11), transcript variant 1 from ORIGENE TECHNOLOGIESLY429116100 ugORIGENE TECHNOLOGIES
Pregnancy specific beta-1-glycoprotein 2 (PSG2) from ORIGENE TECHNOLOGIESLY410601100 ugORIGENE TECHNOLOGIES
Pregnancy specific beta-1-glycoprotein 11 (PSG11), transcript variant 2 from ORIGENE TECHNOLOGIESLY404371100 ugORIGENE TECHNOLOGIES
Pregnancy specific beta-1-glycoprotein 11 (PSG11), transcript variant 3 from ORIGENE TECHNOLOGIESLY426411100 ugORIGENE TECHNOLOGIES
Pregnancy specific beta-1-glycoprotein 4 (PSG4), transcript variant 2 from ORIGENE TECHNOLOGIESLY403872100 ugORIGENE TECHNOLOGIES
Pregnancy specific beta-1-glycoprotein 4 (PSG4), transcript variant 1 from ORIGENE TECHNOLOGIESLY419108100 ugORIGENE TECHNOLOGIES
Pregnancy specific beta-1-glycoprotein 5 (PSG5), transcript variant 1 from ORIGENE TECHNOLOGIESLY419109100 ugORIGENE TECHNOLOGIES
Pregnancy specific beta-1-glycoprotein 6 (PSG6), transcript variant 2 from ORIGENE TECHNOLOGIESLY422207100 ugORIGENE TECHNOLOGIES
Pregnancy specific beta-1-glycoprotein 5 (PSG5), transcript variant 2 from ORIGENE TECHNOLOGIESLY427103100 ugORIGENE TECHNOLOGIES
H2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5075081 kitORIGENE TECHNOLOGIES
H2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5075091 kitORIGENE TECHNOLOGIES
H2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5075061 kitORIGENE TECHNOLOGIES
H2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5075121 kitORIGENE TECHNOLOGIES
H2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5075141 kitORIGENE TECHNOLOGIES
H2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5075151 kitORIGENE TECHNOLOGIES
H2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5075161 kitORIGENE TECHNOLOGIES
H2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5075171 kitORIGENE TECHNOLOGIES
H2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5075181 kitORIGENE TECHNOLOGIES
H2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5075191 kitORIGENE TECHNOLOGIES
H2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5075201 kitORIGENE TECHNOLOGIES
H2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5075211 kitORIGENE TECHNOLOGIES
H2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5075221 kitORIGENE TECHNOLOGIES
H2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5075231 kitORIGENE TECHNOLOGIES
H2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5075241 kitORIGENE TECHNOLOGIES
H2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5075251 kitORIGENE TECHNOLOGIES
H2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5075131 kitORIGENE TECHNOLOGIES
 |< < 145 146 147 148 149 150 151 152 153 > >| 第 147/6274 页